NASDAQ:BTAI

Bioxcel Therapeutics Stock Predictions

etoro logo Buy BTAI
*Your capital is at risk
$1.16
-0.0300 (-2.52%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BTAI Prediction Chart

BTAI Predictions History

Latest community submissions for BTAI.
Predictor Target Session Target Price Result Direction Accuracy Score
Alan Alan Pro @Alan.115878
Jun 22, 2020 $56.12 -93.84% $56.97 X 98.51% 2
JS JS Pro
May 26, 2020 $47.97 -93.48% $45.99 V 95.69% 1
Alan Alan Pro @Alan.115878
May 26, 2020 $47.24 -93.58% $45.99 V 97.28% 1
JS JS Pro
May 11, 2020 $39.16 -94.31% $43.01 V 91.05% 0
Alan Alan Pro @Alan.115878
May 11, 2020 $41.30 -94.00% $43.01 X 96.02% 1
JS JS Pro
May 4, 2020 $33.31 -94.31% $36.62 V 90.96% 0
Alan Alan Pro @Alan.115878
May 4, 2020 $36.48 -93.77% $36.62 X 99.62% 5
JS JS Pro
Apr 27, 2020 $31.44 -93.95% $32.48 X 96.80% 1
Alan Alan Pro @Alan.115878
Apr 27, 2020 $31.86 -93.87% $32.48 X 98.09% 1
JS JS Pro
Mar 30, 2020 $26.34 -93.23% $24.31 X 91.65% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BTAI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOXCEL THERAPEUTICS INC.
BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE